Elevated risk — centralized sequencer dependency on Kraken and instant bridge upgrade authority create single-point-of-failure risks, partially offset by OP Stack battle-tested infrastructure and a clean 15-month security record.
Risk Breakdown
Top Risks
Kraken operates the sole sequencer, meaning regulatory action against the exchange — such as OFAC sanctions, DOJ enforcement, or operational suspension — could halt block production on Ink for up to 12 hours before users can bypass via Ethereum L1 forced inclusion. The SEC dropped its 2023 exchange-operation lawsuit against Kraken in March 2025, but Kraken remains subject to ongoing regulatory oversight as a licensed US exchange.
The Optimism Superchain Security Council holds instant upgrade authority over Ink's bridge and core contracts, with no mandatory exit window for users before changes take effect. L2Beat classifies Ink as Stage 1 specifically because upgrades can be executed without 30-day user exit notice, creating a scenario where bridged assets could be subject to changes before users can withdraw.
Ink launched in December 2024, giving it a track record of just over a year with no security incidents on the chain itself. The DeFi protocols built on top (Tydro, an Aave v3 fork; Nado, a CLOB perp DEX) are relatively new and carry the standard risks of early-stage DeFi deployment, including unresolved edge cases at scale.
The INK governance token is planned but not yet launched as of March 2026, with tokenomics not fully disclosed. Distribution is intended to include Tydro liquidity providers and Kraken users, but insider allocation and Ink Foundation reserve amounts are undisclosed, creating uncertainty about post-launch sell pressure.
Frequently Asked Questions
Is Ink Chain safe to use?
What are the main risks of using Ink Chain?
What is Ink Chain's risk score breakdown?
How does Ink Chain compare to other L2 protocols?
Has Ink Chain ever been hacked or exploited?
Get risk alerts before it's too late
Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.